Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Rxsight Inc (RXST)

Rxsight Inc (RXST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 393,652
  • Shares Outstanding, K 27,722
  • Annual Sales, $ 22,590 K
  • Annual Income, $ -48,690 K
  • 60-Month Beta 0.29
  • Price/Sales 16.91
  • Price/Cash Flow N/A
  • Price/Book 3.97
Trade RXST with:

Options Overview Details

View History
  • Implied Volatility 86.03% ( +16.76%)
  • Historical Volatility 63.14%
  • IV Percentile 68%
  • IV Rank 71.02%
  • IV High 120.00% on 08/30/22
  • IV Low 2.75% on 10/27/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 8
  • Open Int (30-Day) 37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.69
  • Number of Estimates 2
  • High Estimate -0.68
  • Low Estimate -0.69
  • Prior Year -0.58
  • Growth Rate Est. (year over year) -18.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.52 +20.05%
on 11/28/22
14.50 -4.62%
on 11/08/22
+2.13 (+18.21%)
since 11/04/22
3-Month
9.78 +41.41%
on 10/13/22
14.89 -7.09%
on 09/09/22
+1.07 (+8.39%)
since 09/02/22
52-Week
8.80 +57.16%
on 01/07/22
16.99 -18.60%
on 06/08/22
+2.66 (+23.81%)
since 12/03/21

Most Recent Stories

More News
Does RxSight, Inc. (RXST) Have the Potential to Rally 43% as Wall Street Analysts Expect?

The consensus price target hints at a 42.7% upside potential for RxSight, Inc. (RXST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...

RXST : 13.83 (-2.61%)
Wall Street Analysts Predict a 45% Upside in RxSight, Inc. (RXST): Here's What You Should Know

The mean of analysts' price targets for RxSight, Inc. (RXST) points to a 45% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

RXST : 13.83 (-2.61%)
Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?

Here is how Adicet Bio, Inc. (ACET) and RxSight, Inc. (RXST) have performed compared to their sector so far this year.

ACET : 20.19 (+4.83%)
RXST : 13.83 (-2.61%)
RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates

RxSight, Inc. (RXST) delivered earnings and revenue surprises of 12.86% and 19.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

RXST : 13.83 (-2.61%)
NPCE : 1.5800 (unch)
Sensus Healthcare, Inc. (SRTS) Q3 Earnings Lag Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -8.33% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

SRTS : 6.68 (-0.15%)
RXST : 13.83 (-2.61%)
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Should You Buy?

Sight Sciences, Inc. (SGHT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SGHT : 11.71 (-1.84%)
RXST : 13.83 (-2.61%)
RxSight, Inc. (RXST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

RxSight, Inc. (RXST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RXST : 13.83 (-2.61%)
TNDM : 42.44 (-0.73%)
RxSight, Inc. (RXST) Q2 2022 Earnings Call Transcript

RXST earnings call for the period ending June 30, 2022.

RXST : 13.83 (-2.61%)
RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates

RxSight, Inc. (RXST) delivered earnings and revenue surprises of 26.47% and 0.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

RXST : 13.83 (-2.61%)
MASI : 142.55 (-2.03%)
RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 13.83 (-2.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.

See More

Key Turning Points

3rd Resistance Point 14.63
2nd Resistance Point 14.37
1st Resistance Point 14.10
Last Price 13.83
1st Support Level 13.57
2nd Support Level 13.31
3rd Support Level 13.04

See More

52-Week High 16.99
Fibonacci 61.8% 13.86
Last Price 13.83
Fibonacci 50% 12.90
Fibonacci 38.2% 11.93
52-Week Low 8.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar